Melatonin Receptor Agonist [EPC]

Melatonin Receptor Agonist [EPC] was reported 13302 times

Drugs of the Melatonin Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INITIAL INSOMNIA 598 0.0582
1 IRREGULAR SLEEP PHASE 12 0.0566
2 NO ADVERSE REACTION 7 0.0479
3 MIDDLE INSOMNIA 811 0.0434
4 IRREGULAR SLEEP WAKE RHYTHM DISORDER 7 0.0347
5 HANGOVER 82 0.0233
6 GLOSSOPTOSIS 5 0.0228
7 THERAPEUTIC PRODUCT EFFECT DELAYED 97 0.0212
8 CENTRAL HYPOTHYROIDISM 7 0.0211
9 EXCITABILITY 5 0.0183
10 TERMINAL INSOMNIA 32 0.0181
11 SLEEP DEFICIT 37 0.0175
12 POOR QUALITY SLEEP 376 0.0174
13 UPPER RESPIRATORY TRACT INFLAMMATION 18 0.0150
14 GASTROENTERITIS EOSINOPHILIC 5 0.0147
15 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 7 0.0140
16 THERAPEUTIC PRODUCT EFFECT VARIABLE 53 0.0136
17 SLEEP TALKING 22 0.0129
18 ABNORMAL DREAMS 357 0.0129
19 THERAPEUTIC PRODUCT EFFECT INCREASED 15 0.0129
20 STOMA SITE HYPERGRANULATION 8 0.0127
21 NIGHTMARE 418 0.0121
22 CIRCADIAN RHYTHM SLEEP DISORDER 10 0.0121
23 NO ADVERSE DRUG EFFECT 8 0.0118
24 ABNORMAL SLEEP-RELATED EVENT 15 0.0114
25 HYPERMAGNESAEMIA 7 0.0107
26 SKIN CANDIDA 5 0.0096
27 HEART FAILURE WITH REDUCED EJECTION FRACTION 5 0.0093
28 MARASMUS 14 0.0092
29 DRUG EFFECT PROLONGED 5 0.0091
30 THERAPEUTIC RESPONSE INCREASED 8 0.0085
31 DYSLALIA 6 0.0083
32 INCORRECT PRODUCT ADMINISTRATION DURATION 167 0.0077
33 SOMNAMBULISM 47 0.0072
34 OVARIAN CANCER RECURRENT 10 0.0062
35 SLEEP TERROR 26 0.0062
36 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37 0.0061
37 RECTAL ULCER 7 0.0060
38 SLEEP-RELATED EATING DISORDER 5 0.0053
39 SPUTUM RETENTION 5 0.0050
40 HYPERSOMNIA 144 0.0050
41 HYPERCAPNIA 15 0.0050
42 PARADOXICAL DRUG REACTION 18 0.0049
43 HYPERURICAEMIA 20 0.0049
44 GENERALISED ANXIETY DISORDER 7 0.0048
45 THERAPEUTIC PRODUCT EFFECT DECREASED 210 0.0047
46 CARDIAC FAILURE ACUTE 29 0.0043
47 INSOMNIA 1147 0.0043
48 FEMORAL NECK FRACTURE 22 0.0043
49 SOMNOLENCE 830 0.0041
50 GASTROINTESTINAL NECROSIS 12 0.0041
51 SLEEP PARALYSIS 6 0.0041
52 PNEUMONIA ASPIRATION 100 0.0040
53 SELF-MEDICATION 16 0.0039
54 NEPHROGENIC ANAEMIA 18 0.0039
55 ALTERED STATE OF CONSCIOUSNESS 84 0.0039
56 NO ADVERSE EFFECT 7 0.0039
57 DRUG EFFECT INCREASED 12 0.0038
58 INHIBITORY DRUG INTERACTION 6 0.0038
59 PRE-EXISTING CONDITION IMPROVED 23 0.0037
60 METABOLIC SYNDROME 6 0.0036
61 ILLUSION 6 0.0036
62 PSEUDOMEMBRANOUS COLITIS 8 0.0036
63 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
64 THERAPEUTIC RESPONSE DELAYED 10 0.0036
65 HYPOPITUITARISM 6 0.0034
66 EXCESSIVE EYE BLINKING 5 0.0034
67 SLEEP DISORDER 238 0.0034
68 ENTEROCOLITIS 19 0.0033
69 STOMACH DISCOMFORT 17 0.0033
70 INFECTIOUS PLEURAL EFFUSION 5 0.0033
71 DIABETIC NEUROPATHY 16 0.0032
72 GASTROSTOMY 5 0.0032
73 HYPERPARATHYROIDISM SECONDARY 8 0.0032
74 NARCOLEPSY 6 0.0032
75 SPINAL COMPRESSION FRACTURE 26 0.0031
76 CANCER PAIN 8 0.0031
77 EMBOLIC STROKE 11 0.0031
78 PHYSICAL DECONDITIONING 8 0.0031
79 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
80 CARDIAC FAILURE CHRONIC 13 0.0030
81 HYPERNATRAEMIA 15 0.0030
82 DRUG ERUPTION 53 0.0030
83 SMALL INTESTINAL HAEMORRHAGE 6 0.0030
84 DELIRIUM 103 0.0030
85 PNEUMONIA BACTERIAL 27 0.0029
86 ILEUS PARALYTIC 13 0.0029
87 RESTLESSNESS 106 0.0029
88 FEELING JITTERY 55 0.0029
89 AORTIC VALVE STENOSIS 5 0.0028
90 BEHAVIOUR DISORDER 15 0.0028
91 SEDATION COMPLICATION 7 0.0027
92 TRAUMATIC HAEMORRHAGE 5 0.0027
93 HEPATIC FUNCTION ABNORMAL 99 0.0026
94 PERIARTHRITIS 6 0.0026
95 HALLUCINATIONS, MIXED 11 0.0026
96 BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0026
97 PANIC DISORDER 10 0.0026
98 DRUG DISPENSING ERROR 39 0.0025
99 PULMONARY INFARCTION 6 0.0025
100 PSYCHIATRIC SYMPTOM 18 0.0024
101 DRUG TOLERANCE 12 0.0024
102 HEPATITIS FULMINANT 7 0.0024
103 INCORRECT DRUG ADMINISTRATION DURATION 66 0.0023
104 HEPATOSPLENOMEGALY 6 0.0023
105 DEREALISATION 5 0.0023
106 FEELING DRUNK 17 0.0023
107 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
108 POST-TRAUMATIC STRESS DISORDER 15 0.0022
109 ENURESIS 9 0.0022
110 SLEEP APNOEA SYNDROME 42 0.0022
111 RESTLESS LEGS SYNDROME 40 0.0022
112 SCREAMING 14 0.0022
113 ILEUS 27 0.0022
114 TOXIC ENCEPHALOPATHY 11 0.0022
115 FLAT AFFECT 5 0.0022
116 PRODUCT DOSE OMISSION 141 0.0022
117 DRUG EFFECT LESS THAN EXPECTED 32 0.0022
118 DRUG SCREEN POSITIVE 17 0.0021
119 DECUBITUS ULCER 17 0.0021
120 NOCTURIA 25 0.0021
121 SLUGGISHNESS 21 0.0021
122 PSYCHOMOTOR HYPERACTIVITY 34 0.0020
123 EOSINOPHIL COUNT INCREASED 17 0.0020
124 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
125 REBOUND ACID HYPERSECRETION 6 0.0020
126 ENDODONTIC PROCEDURE 5 0.0020
127 DYSLIPIDAEMIA 10 0.0020
128 HAEMORRHAGIC DIATHESIS 7 0.0020
129 PRESCRIBED OVERDOSE 38 0.0020
130 INTERSTITIAL LUNG DISEASE 95 0.0020
131 DRUG INEFFECTIVE 2573 0.0020
132 HALLUCINATION 147 0.0019
133 NEUROLEPTIC MALIGNANT SYNDROME 23 0.0019
134 LUNG OPACITY 5 0.0019
135 GALACTORRHOEA 12 0.0019
136 HUMERUS FRACTURE 9 0.0019
137 IMPULSIVE BEHAVIOUR 7 0.0019
138 SKIN EROSION 6 0.0019
139 CEREBRAL INFARCTION 45 0.0018
140 PRODUCT DOSE OMISSION ISSUE 541 0.0018
141 STOMA SITE DISCHARGE 5 0.0018
142 STAPHYLOCOCCAL SEPSIS 9 0.0018
143 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
144 THINKING ABNORMAL 33 0.0018
145 SEASONAL ALLERGY 25 0.0018
146 ATELECTASIS 17 0.0018
147 SEDATION 46 0.0018
148 PERIPHERAL VASCULAR DISORDER 9 0.0017
149 REGURGITATION 6 0.0017
150 PYELONEPHRITIS 15 0.0017
151 GALLBLADDER OPERATION 7 0.0017
152 PRODUCT DISTRIBUTION ISSUE 16 0.0017
153 HAEMOTHORAX 5 0.0017
154 GOITRE 7 0.0017
155 HALLUCINATION, VISUAL 36 0.0017
156 DEPRESSIVE SYMPTOM 6 0.0017
157 BLOOD PROLACTIN INCREASED 8 0.0017
158 DECREASED ACTIVITY 18 0.0017
159 FACIAL BONES FRACTURE 6 0.0017
160 EMBOLISM VENOUS 5 0.0016
161 SCHIZOPHRENIA 20 0.0016
162 MANIA 27 0.0016
163 PARKINSONISM 16 0.0016
164 INTESTINAL ISCHAEMIA 9 0.0016
165 ORGANISING PNEUMONIA 8 0.0016
166 CHOLECYSTITIS ACUTE 9 0.0016
167 GENERALISED ERYTHEMA 9 0.0016
168 ORTHOPNOEA 5 0.0016
169 FAILURE TO THRIVE 8 0.0015
170 BREAST ENLARGEMENT 5 0.0015
171 PNEUMONIA FUNGAL 6 0.0015
172 IRON DEFICIENCY ANAEMIA 14 0.0015
173 HYPERLIPIDAEMIA 18 0.0015
174 MAJOR DEPRESSION 11 0.0015
175 THERAPEUTIC AGENT TOXICITY 5 0.0015
176 FOOD POISONING 8 0.0015
177 TRIGEMINAL NEURALGIA 6 0.0015
178 POTENTIATING DRUG INTERACTION 5 0.0015
179 VITAMIN B12 DEFICIENCY 6 0.0015
180 DELUSION 23 0.0015
181 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
182 TENSION 9 0.0015
183 DEPRESSED LEVEL OF CONSCIOUSNESS 58 0.0015
184 OESOPHAGITIS 16 0.0015
185 BLOOD TESTOSTERONE DECREASED 10 0.0015
186 PEMPHIGOID 11 0.0015
187 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 9 0.0015
188 HALLUCINATION, AUDITORY 23 0.0014
189 TACHYPHRENIA 5 0.0014
190 AGITATION 106 0.0014
191 HEMIPLEGIA 12 0.0014
192 PHOTOPSIA 9 0.0014
193 INCONTINENCE 15 0.0014
194 LIGAMENT SPRAIN 14 0.0014
195 AORTIC VALVE INCOMPETENCE 6 0.0014
196 COLON CANCER 21 0.0014
197 ACUTE RESPIRATORY FAILURE 27 0.0014
198 HEPATIC STEATOSIS 26 0.0014
199 ABNORMAL SENSATION IN EYE 6 0.0014
200 PARANOIA 24 0.0014
201 FEELING ABNORMAL 333 0.0014
202 INTENTIONAL OVERDOSE 89 0.0014
203 BLOOD ALBUMIN DECREASED 11 0.0014
204 MONOPLEGIA 6 0.0014
205 BIPOLAR DISORDER 15 0.0014
206 SUBARACHNOID HAEMORRHAGE 14 0.0014
207 DRUG EFFECT DECREASED 74 0.0014
208 DISTURBANCE IN ATTENTION 74 0.0014
209 ENDOCARDITIS 7 0.0014
210 HUNGER 19 0.0014
211 MYASTHENIA GRAVIS 11 0.0014
212 MIGRAINE 130 0.0014
213 APPETITE DISORDER 9 0.0014
214 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
215 BLOOD CREATINE INCREASED 6 0.0014
216 VARICOSE VEIN 7 0.0014
217 SHOCK HAEMORRHAGIC 11 0.0013
218 MALNUTRITION 15 0.0013
219 NERVOUSNESS 70 0.0013
220 URINARY TRACT DISORDER 6 0.0013
221 IRRITABILITY 80 0.0013
222 MITRAL VALVE INCOMPETENCE 15 0.0013
223 DRUG EFFECT DELAYED 6 0.0013
224 OBESITY 21 0.0013
225 PARANASAL SINUS HYPERSECRETION 5 0.0013
226 ACIDOSIS 10 0.0013
227 LARGE INTESTINE POLYP 9 0.0013
228 LARGE INTESTINE PERFORATION 9 0.0013
229 EMPHYSEMA 13 0.0013
230 HYPOALBUMINAEMIA 10 0.0013
231 RENAL IMPAIRMENT 108 0.0013
232 DYSKINESIA 52 0.0013
233 FAECALOMA 7 0.0013
234 NASAL DRYNESS 8 0.0013
235 VAGINAL INFECTION 6 0.0013
236 MELAENA 28 0.0013
237 EUPHORIC MOOD 13 0.0013
238 EATING DISORDER 27 0.0013
239 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
240 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0013
241 HEART RATE ABNORMAL 7 0.0013
242 ECONOMIC PROBLEM 19 0.0013
243 SPINAL OSTEOARTHRITIS 11 0.0013
244 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
245 SEROTONIN SYNDROME 24 0.0012
246 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
247 CHRONIC KIDNEY DISEASE 94 0.0012
248 SUDDEN DEATH 13 0.0012
249 RESPIRATORY DEPRESSION 15 0.0012
250 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 220 0.0012
251 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
252 HEPATIC ENZYME ABNORMAL 6 0.0012
253 GASTROINTESTINAL PERFORATION 5 0.0012
254 SUICIDAL BEHAVIOUR 5 0.0012
255 SALIVARY HYPERSECRETION 12 0.0012
256 BLOOD LACTATE DEHYDROGENASE INCREASED 19 0.0012
257 LYMPHOCYTE COUNT DECREASED 21 0.0012
258 COLITIS ISCHAEMIC 8 0.0012
259 DYSPHORIA 6 0.0012
260 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
261 ERYTHEMA MULTIFORME 11 0.0012
262 DRUG TOXICITY 16 0.0012
263 MOOD ALTERED 32 0.0012
264 LIVER DISORDER 52 0.0012
265 TRISMUS 6 0.0012
266 END STAGE RENAL DISEASE 21 0.0012
267 DERMATITIS ACNEIFORM 7 0.0011
268 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
269 FORMICATION 8 0.0011
270 PAPULE 8 0.0011
271 RHINITIS ALLERGIC 5 0.0011
272 COMPRESSION FRACTURE 6 0.0011
273 SUBDURAL HAEMATOMA 16 0.0011
274 FRUSTRATION TOLERANCE DECREASED 9 0.0011
275 BRUXISM 6 0.0011
276 BLEPHAROSPASM 7 0.0011
277 CHEILITIS 6 0.0011
278 BLADDER DISORDER 11 0.0011
279 RHABDOMYOLYSIS 46 0.0011
280 RESPIRATORY FAILURE 80 0.0011
281 ASPIRATION 12 0.0011
282 ASTHENOPIA 6 0.0011
283 PRODUCT PRESCRIBING ERROR 26 0.0011
284 ANXIETY 310 0.0011
285 INTENTIONAL SELF-INJURY 22 0.0011
286 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
287 DISORIENTATION 43 0.0011
288 DRUG INTERACTION 172 0.0011
289 DIABETIC KETOACIDOSIS 26 0.0011
290 INCOHERENT 7 0.0011
291 FEELING OF DESPAIR 5 0.0011
292 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
293 SCIATICA 17 0.0011
294 PULMONARY CONGESTION 14 0.0011
295 TREATMENT NONCOMPLIANCE 58 0.0011
296 INTENTIONAL DOSE OMISSION 30 0.0011
297 HYPERTHERMIA 8 0.0010
298 INCREASED APPETITE 20 0.0010
299 VISUAL DISTURBANCE 6 0.0010
300 URINARY TRACT INFECTION 178 0.0010
301 WRONG PRODUCT ADMINISTERED 7 0.0010
302 HEADACHE 649 0.0010
303 SINUS BRADYCARDIA 10 0.0010
304 VENTRICULAR TACHYCARDIA 17 0.0010
305 APATHY 15 0.0010
306 APNOEA 8 0.0010
307 PELVIC FRACTURE 8 0.0010
308 HYPERKALAEMIA 36 0.0010
309 BLOOD PRESSURE DECREASED 68 0.0010
310 TUMOUR LYSIS SYNDROME 9 0.0010
311 URINARY RETENTION 34 0.0010
312 HYPOKALAEMIA 47 0.0010
313 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
314 ENERGY INCREASED 6 0.0010
315 SINUS HEADACHE 6 0.0010
316 CARDIAC FAILURE 81 0.0010
317 THIRST 18 0.0010
318 CHOLECYSTITIS 12 0.0010
319 ATRIAL FLUTTER 8 0.0010
320 PRESCRIBED UNDERDOSE 20 0.0010
321 FLUID INTAKE REDUCED 5 0.0010
322 AGGRESSION 50 0.0010
323 GASTROENTERITIS VIRAL 18 0.0010
324 TYPE 1 DIABETES MELLITUS 6 0.0010
325 MUSCLE TIGHTNESS 16 0.0010
326 ABNORMAL BEHAVIOUR 39 0.0010
327 ASPHYXIA 8 0.0010
328 NEUTROPHIL COUNT INCREASED 10 0.0010
329 DEPRESSION 222 0.0010
330 DEVICE RELATED INFECTION 15 0.0010
331 PERSONALITY CHANGE 9 0.0010
332 FEAR 26 0.0010
333 EXTRAPYRAMIDAL DISORDER 24 0.0010
334 BACTERIAL INFECTION 18 0.0010
335 ACTIVITIES OF DAILY LIVING IMPAIRED 19 0.0010
336 HAEMATOCRIT DECREASED 19 0.0010
337 BLOOD UREA INCREASED 16 0.0010
338 ORAL DISORDER 7 0.0010
339 IMPAIRED GASTRIC EMPTYING 13 0.0010
340 HYPOCALCAEMIA 18 0.0010
341 BLOOD LACTIC ACID INCREASED 5 0.0009
342 ALANINE AMINOTRANSFERASE INCREASED 58 0.0009
343 HYPOTHYROIDISM 30 0.0009
344 HYDRONEPHROSIS 7 0.0009
345 PANIC ATTACK 34 0.0009
346 BREAST TENDERNESS 7 0.0009
347 HIATUS HERNIA 12 0.0009
348 ORTHOSTATIC HYPOTENSION 16 0.0009
349 ASCITES 27 0.0009
350 DIABETES MELLITUS 70 0.0009
351 PRODUCT DOSE OMISSION IN ERROR 26 0.0009
352 HYDROCEPHALUS 5 0.0009
353 WRIST FRACTURE 11 0.0009
354 EPILEPSY 28 0.0009
355 SINUS TACHYCARDIA 13 0.0009
356 URINE OUTPUT DECREASED 8 0.0009
357 MEMORY IMPAIRMENT 125 0.0009
358 ANKLE FRACTURE 14 0.0009
359 BLOOD CREATINE PHOSPHOKINASE INCREASED 26 0.0009
360 RENAL DISORDER 42 0.0009
361 ON AND OFF PHENOMENON 5 0.0009
362 WRONG DRUG ADMINISTERED 8 0.0009
363 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
364 ERECTILE DYSFUNCTION 23 0.0009
365 FALL 298 0.0009
366 BREAST MASS 6 0.0009
367 MULTIPLE ALLERGIES 7 0.0009
368 HYPOGLYCAEMIA 43 0.0009
369 HEAD INJURY 28 0.0009
370 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
371 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
372 OSTEOMYELITIS 16 0.0009
373 IMPAIRED DRIVING ABILITY 10 0.0009
374 C-REACTIVE PROTEIN INCREASED 32 0.0009
375 AKATHISIA 12 0.0009
376 EYE MOVEMENT DISORDER 6 0.0009
377 NEUROLOGICAL SYMPTOM 5 0.0009
378 FEBRILE NEUTROPENIA 58 0.0009
379 CELLULITIS 44 0.0009
380 BRAIN NEOPLASM 8 0.0009
381 RESPIRATION ABNORMAL 6 0.0009
382 GASTROOESOPHAGEAL REFLUX DISEASE 70 0.0009
383 DYSURIA 32 0.0009
384 DROOLING 6 0.0009
385 RHINITIS 7 0.0009
386 LYMPHOEDEMA 6 0.0009
387 MUSCLE TWITCHING 20 0.0009
388 BLOOD URIC ACID INCREASED 5 0.0009
389 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
390 SUICIDAL IDEATION 79 0.0009
391 BLOOD POTASSIUM INCREASED 14 0.0009
392 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
393 TYPE 2 DIABETES MELLITUS 29 0.0009
394 HYPOPHAGIA 22 0.0009
395 HEPATIC ENCEPHALOPATHY 8 0.0009
396 DECREASED APPETITE 199 0.0009
397 DYSPHAGIA 81 0.0009
398 PHOTOPHOBIA 16 0.0008
399 DRY MOUTH 69 0.0008
400 MENTAL DISORDER 37 0.0008
401 DYSARTHRIA 32 0.0008
402 PULMONARY TOXICITY 6 0.0008
403 HEAD DISCOMFORT 15 0.0008
404 BRADYKINESIA 5 0.0008
405 COVID-19 PNEUMONIA 10 0.0008
406 MENSTRUAL DISORDER 7 0.0008
407 FOOT FRACTURE 16 0.0008
408 CYTOMEGALOVIRUS INFECTION 14 0.0008
409 CEREBRAL HAEMORRHAGE 30 0.0008
410 HYPONATRAEMIA 47 0.0008
411 DRUG PRESCRIBING ERROR 16 0.0008
412 AFFECT LABILITY 8 0.0008
413 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 59 0.0008
414 HYPERCHOLESTEROLAEMIA 8 0.0008
415 ANGER 28 0.0008
416 PLATELET COUNT DECREASED 88 0.0008
417 DIZZINESS POSTURAL 8 0.0008
418 SUICIDE ATTEMPT 50 0.0008
419 ADRENAL INSUFFICIENCY 10 0.0008
420 FIBROMYALGIA 20 0.0008
421 GASTROENTERITIS 12 0.0008
422 NO THERAPEUTIC RESPONSE 10 0.0008
423 CARDIOMEGALY 10 0.0008
424 ANAEMIA 155 0.0008
425 HYPOPHOSPHATAEMIA 6 0.0008
426 BRADYCARDIA 43 0.0008
427 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
428 LIMB INJURY 22 0.0008
429 FEMUR FRACTURE 25 0.0008
430 RESPIRATORY TRACT INFECTION 21 0.0008
431 TINNITUS 37 0.0008
432 TREMOR 133 0.0008
433 AMNESIA 52 0.0008
434 CRYING 29 0.0008
435 FRACTURE 15 0.0008
436 PRODUCT ADMINISTRATION ERROR 16 0.0008
437 COORDINATION ABNORMAL 11 0.0008
438 MENTAL IMPAIRMENT 19 0.0008
439 BOWEL MOVEMENT IRREGULARITY 6 0.0008
440 DISSOCIATION 6 0.0008
441 SHOCK 18 0.0008
442 ENTERITIS 5 0.0008
443 THERAPEUTIC RESPONSE UNEXPECTED 35 0.0008
444 TARDIVE DYSKINESIA 22 0.0008
445 NIGHT SWEATS 25 0.0008
446 DIZZINESS 386 0.0008
447 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 5 0.0008
448 POLLAKIURIA 32 0.0008
449 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
450 EXOSTOSIS 7 0.0008
451 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
452 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
453 DYSGRAPHIA 5 0.0008
454 TOOTH INFECTION 10 0.0008
455 BACTERAEMIA 9 0.0008
456 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
457 CORONAVIRUS INFECTION 5 0.0008
458 WHITE BLOOD CELL COUNT INCREASED 29 0.0008
459 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
460 MYOCLONUS 9 0.0008
461 ACCIDENT 9 0.0008
462 EAR INFECTION 20 0.0008
463 DEMENTIA 21 0.0008
464 CYTOKINE RELEASE SYNDROME 15 0.0007
465 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
466 CHOLECYSTITIS CHRONIC 5 0.0007
467 IRRITABLE BOWEL SYNDROME 16 0.0007
468 STOMATITIS 45 0.0007
469 SKIN LACERATION 8 0.0007
470 BACK INJURY 8 0.0007
471 RESPIRATORY DISORDER 22 0.0007
472 RASH GENERALISED 19 0.0007
473 LETHARGY 42 0.0007
474 HYPOAESTHESIA ORAL 11 0.0007
475 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
476 ILLNESS 75 0.0007
477 INFLUENZA 81 0.0007
478 RESPIRATORY ARREST 20 0.0007
479 PHARYNGITIS 9 0.0007
480 ADVERSE DRUG REACTION 65 0.0007
481 VENTRICULAR FIBRILLATION 8 0.0007
482 MENTAL STATUS CHANGES 20 0.0007
483 PNEUMONIA 233 0.0007
484 SEIZURE 83 0.0007
485 PALPITATIONS 84 0.0007
486 EXTRASYSTOLES 5 0.0007
487 ADVERSE EVENT 66 0.0007
488 RENAL FAILURE 95 0.0007
489 PHARYNGEAL OEDEMA 11 0.0007
490 PANCREATITIS ACUTE 16 0.0007
491 INFUSION SITE ERYTHEMA 6 0.0007
492 NEUTROPHIL COUNT DECREASED 29 0.0007
493 PLEURAL EFFUSION 43 0.0007
494 HAND FRACTURE 5 0.0007
495 ACUTE KIDNEY INJURY 108 0.0007
496 VERTIGO 43 0.0007
497 VITAMIN D DECREASED 6 0.0007
498 BRAIN FOG 11 0.0007
499 CONSTIPATION 153 0.0007
500 DERMATITIS CONTACT 8 0.0007
501 MICTURITION URGENCY 8 0.0007
502 SEPSIS 78 0.0007
503 INFUSION SITE PAIN 9 0.0007
504 PRURITUS GENERALISED 15 0.0007
505 HYSTERECTOMY 6 0.0007
506 PANIC REACTION 5 0.0007
507 METASTASES TO LUNG 8 0.0007
508 WITHDRAWAL SYNDROME 29 0.0007
509 SENSORY DISTURBANCE 11 0.0007
510 BEDRIDDEN 9 0.0007
511 AMENORRHOEA 12 0.0007
512 OEDEMA 37 0.0007
513 PSYCHOTIC DISORDER 20 0.0007
514 WEIGHT INCREASED 151 0.0007
515 COVID-19 118 0.0007
516 ROAD TRAFFIC ACCIDENT 28 0.0007
517 JAUNDICE 18 0.0007
518 TRANSFUSION 7 0.0007
519 STAPHYLOCOCCAL INFECTION 22 0.0007
520 SEPTIC SHOCK 29 0.0007
521 HEART RATE INCREASED 66 0.0007
522 PHOTOSENSITIVITY REACTION 11 0.0007
523 OEDEMA PERIPHERAL 81 0.0007
524 OROPHARYNGEAL DISCOMFORT 6 0.0007
525 TOOTHACHE 12 0.0007
526 PAROSMIA 5 0.0007
527 KIDNEY INFECTION 13 0.0007
528 FATIGUE 514 0.0007
529 PRODUCT USE ISSUE 124 0.0007
530 HEPATOCELLULAR CARCINOMA 5 0.0007
531 TROPONIN INCREASED 5 0.0007
532 LOSS OF CONSCIOUSNESS 84 0.0007
533 PERIPHERAL COLDNESS 9 0.0007
534 SMALL INTESTINAL OBSTRUCTION 8 0.0006
535 THYROID DISORDER 10 0.0006
536 FOOD ALLERGY 5 0.0006
537 MEDICATION ERROR 36 0.0006
538 ANHEDONIA 17 0.0006
539 HEPATIC ENZYME INCREASED 44 0.0006
540 HAEMOPTYSIS 18 0.0006
541 DEPRESSED MOOD 34 0.0006
542 DYSPEPSIA 63 0.0006
543 LACERATION 6 0.0006
544 ARTERIOSCLEROSIS 6 0.0006
545 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
546 POISONING 8 0.0006
547 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
548 TOOTH FRACTURE 7 0.0006
549 OSTEOPOROSIS 26 0.0006
550 PROTEINURIA 12 0.0006
551 RED BLOOD CELL COUNT DECREASED 18 0.0006
552 RENAL CYST 5 0.0006
553 TRICUSPID VALVE INCOMPETENCE 5 0.0006
554 MOOD SWINGS 20 0.0006
555 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
556 MALAISE 274 0.0006
557 PULMONARY HYPERTENSION 13 0.0006
558 GLAUCOMA 12 0.0006
559 DEHYDRATION 83 0.0006
560 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
561 DYSGEUSIA 46 0.0006
562 NAUSEA 489 0.0006
563 GALLBLADDER DISORDER 11 0.0006
564 EPISTAXIS 46 0.0006
565 POST PROCEDURAL INFECTION 5 0.0006
566 BALANCE DISORDER 53 0.0006
567 CONVULSION 35 0.0006
568 OVERDOSE 132 0.0006
569 WEIGHT DECREASED 170 0.0006
570 URINARY INCONTINENCE 18 0.0006
571 CONFUSIONAL STATE 98 0.0006
572 PULMONARY MASS 9 0.0006
573 NASOPHARYNGITIS 111 0.0006
574 BLOOD CHOLESTEROL INCREASED 28 0.0006
575 BLOOD POTASSIUM DECREASED 18 0.0006
576 CARDIO-RESPIRATORY ARREST 25 0.0006
577 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
578 FACE OEDEMA 10 0.0006
579 DRY THROAT 6 0.0006
580 DISCOMFORT 36 0.0006
581 TOOTH ABSCESS 6 0.0006
582 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
583 UNRESPONSIVE TO STIMULI 15 0.0006
584 PERITONITIS 12 0.0006
585 DIPLOPIA 15 0.0006
586 SWOLLEN TONGUE 18 0.0006
587 HYPERGLYCAEMIA 21 0.0006
588 SINUSITIS 59 0.0006
589 FEELING COLD 16 0.0006
590 ACCIDENTAL OVERDOSE 21 0.0006
591 DRUG-INDUCED LIVER INJURY 18 0.0006
592 ABDOMINAL DISCOMFORT 96 0.0006
593 PYREXIA 198 0.0006
594 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
595 CARDIAC ARREST 47 0.0006
596 HYPERHIDROSIS 73 0.0006
597 LUNG INFILTRATION 5 0.0006
598 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
599 PURPURA 5 0.0006
600 HAEMORRHOIDS 11 0.0006
601 BLOOD PRESSURE INCREASED 86 0.0006
602 TOOTH EXTRACTION 7 0.0006
603 VOMITING 264 0.0006
604 BODY HEIGHT DECREASED 6 0.0006
605 HAEMOLYTIC ANAEMIA 5 0.0006
606 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
607 BRONCHITIS 41 0.0006
608 SPEECH DISORDER 29 0.0006
609 ARRHYTHMIA 26 0.0005
610 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
611 PRODUCT PHYSICAL ISSUE 11 0.0005
612 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
613 OSTEOARTHRITIS 23 0.0005
614 DENTAL CARIES 6 0.0005
615 RHINORRHOEA 35 0.0005
616 BLOOD GLUCOSE ABNORMAL 10 0.0005
617 STEVENS-JOHNSON SYNDROME 12 0.0005
618 HYPOXIA 19 0.0005
619 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
620 DEEP VEIN THROMBOSIS 35 0.0005
621 APPENDICITIS 5 0.0005
622 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
623 NEURALGIA 13 0.0005
624 CYSTITIS 17 0.0005
625 ORAL CANDIDIASIS 7 0.0005
626 STATUS EPILEPTICUS 6 0.0005
627 REBOUND EFFECT 6 0.0005
628 LUNG DISORDER 26 0.0005
629 DYSMENORRHOEA 7 0.0005
630 SPINAL DISORDER 5 0.0005
631 OSTEOPENIA 8 0.0005
632 MUSCULOSKELETAL DISCOMFORT 9 0.0005
633 HERPES ZOSTER 30 0.0005
634 PERICARDIAL EFFUSION 12 0.0005
635 PANCYTOPENIA 29 0.0005
636 BLOOD BILIRUBIN INCREASED 14 0.0005
637 THROAT TIGHTNESS 14 0.0005
638 ERUCTATION 10 0.0005
639 ELECTROLYTE IMBALANCE 6 0.0005
640 LIVER FUNCTION TEST ABNORMAL 15 0.0005
641 JOINT INJURY 11 0.0005
642 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
643 EAR PAIN 10 0.0005
644 CARDIAC FAILURE CONGESTIVE 41 0.0005
645 FUNGAL INFECTION 17 0.0005
646 COELIAC DISEASE 5 0.0005
647 HEPATOMEGALY 5 0.0005
648 CYANOSIS 8 0.0005
649 DRUG DOSE OMISSION 84 0.0005
650 BODY TEMPERATURE DECREASED 5 0.0005
651 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
652 RENAL INJURY 15 0.0005
653 COMPLETED SUICIDE 42 0.0005
654 CARPAL TUNNEL SYNDROME 7 0.0005
655 MOVEMENT DISORDER 16 0.0005
656 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
657 WHITE BLOOD CELL COUNT DECREASED 54 0.0005
658 HAEMOGLOBIN DECREASED 51 0.0005
659 HAEMATURIA 17 0.0005
660 TACHYCARDIA 44 0.0005
661 RASH MACULO-PAPULAR 11 0.0005
662 PAIN IN JAW 14 0.0005
663 HYPOTHERMIA 5 0.0005
664 FEEDING DISORDER 10 0.0005
665 MUSCULAR WEAKNESS 56 0.0005
666 UNEVALUABLE EVENT 37 0.0005
667 PARALYSIS 7 0.0005
668 MUSCLE SPASTICITY 6 0.0005
669 CONDITION AGGRAVATED 148 0.0005
670 RIB FRACTURE 10 0.0005
671 HYPERTHYROIDISM 7 0.0005
672 HYPERBILIRUBINAEMIA 5 0.0005
673 HYPERTENSION 102 0.0005
674 VIRAL INFECTION 16 0.0005
675 TENDERNESS 5 0.0005
676 INTENTIONAL DRUG MISUSE 10 0.0005
677 NASAL CONGESTION 28 0.0005
678 BRAIN OEDEMA 6 0.0005
679 BLOOD CREATININE INCREASED 31 0.0005
680 CANDIDA INFECTION 8 0.0005
681 HYPOTENSION 95 0.0005
682 PULMONARY EMBOLISM 45 0.0005
683 ASTHENIA 178 0.0005
684 HAEMATEMESIS 12 0.0005
685 PANCREATITIS 25 0.0005
686 MUSCULOSKELETAL DISORDER 9 0.0005
687 RENAL PAIN 5 0.0005
688 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
689 COGNITIVE DISORDER 22 0.0005
690 CIRCULATORY COLLAPSE 8 0.0005
691 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
692 ROTATOR CUFF SYNDROME 6 0.0005
693 LIVER FUNCTION TEST INCREASED 10 0.0005
694 UNDERDOSE 34 0.0005
695 ANOREXIA 6 0.0005
696 LACTIC ACIDOSIS 15 0.0005
697 OXYGEN SATURATION DECREASED 26 0.0005
698 ATRIAL FIBRILLATION 45 0.0005
699 ORAL HERPES 9 0.0005
700 MUSCLE SPASMS 84 0.0005
701 CHOLELITHIASIS 15 0.0005
702 CONTUSION 44 0.0005
703 BLOOD GLUCOSE FLUCTUATION 5 0.0005
704 GASTRITIS 12 0.0005
705 DISABILITY 9 0.0005
706 LYMPHOMA 7 0.0005
707 ADVERSE REACTION 6 0.0005
708 PRESYNCOPE 11 0.0005
709 ABDOMINAL PAIN UPPER 93 0.0005
710 EJECTION FRACTION DECREASED 7 0.0004
711 NERVE INJURY 5 0.0004
712 COUGH 126 0.0004
713 CARDIAC DISORDER 42 0.0004
714 THERAPY CESSATION 23 0.0004
715 HYPERSENSITIVITY 83 0.0004
716 DIARRHOEA 288 0.0004
717 SNEEZING 10 0.0004
718 THROAT IRRITATION 20 0.0004
719 OCULAR DISCOMFORT 5 0.0004
720 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
721 GAIT DISTURBANCE 85 0.0004
722 BACK PAIN 103 0.0004
723 PRODUCT TASTE ABNORMAL 6 0.0004
724 INCORRECT DOSE ADMINISTERED 101 0.0004
725 PNEUMOTHORAX 7 0.0004
726 COMA 21 0.0004
727 ULCER 7 0.0004
728 MYOCARDIAL ISCHAEMIA 5 0.0004
729 HOT FLUSH 33 0.0004
730 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
731 TOOTH LOSS 9 0.0004
732 DIVERTICULITIS 12 0.0004
733 HYPOMAGNESAEMIA 6 0.0004
734 EYELID OEDEMA 5 0.0004
735 POST PROCEDURAL HAEMORRHAGE 5 0.0004
736 VASCULITIS 5 0.0004
737 HEART RATE DECREASED 15 0.0004
738 BLOOD TEST ABNORMAL 6 0.0004
739 EYE DISORDER 14 0.0004
740 HEPATIC CIRRHOSIS 8 0.0004
741 DYSPNOEA EXERTIONAL 16 0.0004
742 RASH PRURITIC 23 0.0004
743 FEELING HOT 26 0.0004
744 DIALYSIS 6 0.0004
745 COLITIS 16 0.0004
746 BLOOD IRON DECREASED 5 0.0004
747 IMPAIRED WORK ABILITY 9 0.0004
748 NEUROPATHY PERIPHERAL 40 0.0004
749 COAGULOPATHY 7 0.0004
750 MALIGNANT NEOPLASM PROGRESSION 43 0.0004
751 ANGINA PECTORIS 12 0.0004
752 GASTROINTESTINAL HAEMORRHAGE 35 0.0004
753 CARDIOGENIC SHOCK 6 0.0004
754 MUSCLE RIGIDITY 5 0.0004
755 BLOOD GLUCOSE DECREASED 20 0.0004
756 MYELODYSPLASTIC SYNDROME 6 0.0004
757 NEPHROLITHIASIS 19 0.0004
758 HERNIA 8 0.0004
759 LOCALISED INFECTION 10 0.0004
760 HYPOKINESIA 6 0.0004
761 DRUG EFFECT INCOMPLETE 15 0.0004
762 BURSITIS 5 0.0004
763 DYSSTASIA 12 0.0004
764 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
765 CHOKING 8 0.0004
766 SURGERY 24 0.0004
767 SCAR 7 0.0004
768 GASTRIC DISORDER 14 0.0004
769 ASTHMA 46 0.0004
770 SPINAL OPERATION 5 0.0004
771 TOOTH DISORDER 9 0.0004
772 SINUS DISORDER 8 0.0004
773 CYST 5 0.0004
774 BLOOD PRESSURE ABNORMAL 8 0.0004
775 SPINAL FRACTURE 8 0.0004
776 METASTASES TO LIVER 7 0.0004
777 HEPATIC FAILURE 12 0.0004
778 TOXICITY TO VARIOUS AGENTS 67 0.0004
779 COLD SWEAT 7 0.0004
780 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
781 BONE MARROW FAILURE 8 0.0004
782 NECK PAIN 22 0.0004
783 FLUID RETENTION 20 0.0004
784 HIP ARTHROPLASTY 6 0.0004
785 OROPHARYNGEAL PAIN 36 0.0004
786 LIMB DISCOMFORT 12 0.0004
787 MUSCULOSKELETAL CHEST PAIN 6 0.0004
788 SKIN ULCER 10 0.0004
789 HAEMATOMA 10 0.0004
790 INJURY 27 0.0004
791 DERMATITIS 8 0.0004
792 HYPOAESTHESIA 57 0.0004
793 HAEMATOCHEZIA 21 0.0004
794 RASH 165 0.0004
795 RESPIRATORY TRACT CONGESTION 6 0.0004
796 CONJUNCTIVITIS 7 0.0004
797 PRODUCTIVE COUGH 18 0.0004
798 MALIGNANT MELANOMA 5 0.0004
799 ACUTE MYOCARDIAL INFARCTION 11 0.0004
800 LABORATORY TEST ABNORMAL 11 0.0004
801 CHEST PAIN 69 0.0004
802 EYE PAIN 21 0.0004
803 INTESTINAL OBSTRUCTION 14 0.0004
804 BLOOD SODIUM DECREASED 7 0.0004
805 SINUS CONGESTION 5 0.0004
806 SYNCOPE 37 0.0004
807 BACK DISORDER 6 0.0004
808 TACHYPNOEA 5 0.0004
809 PNEUMONITIS 10 0.0004
810 ENCEPHALOPATHY 9 0.0004
811 LOWER LIMB FRACTURE 7 0.0004
812 ABASIA 9 0.0004
813 THERAPY INTERRUPTED 26 0.0004
814 OSTEONECROSIS OF JAW 9 0.0004
815 APPLICATION SITE RASH 5 0.0004
816 THERAPEUTIC RESPONSE DECREASED 22 0.0004
817 DRUG LEVEL INCREASED 6 0.0004
818 DYSTONIA 7 0.0004
819 DYSPHONIA 21 0.0004
820 NO ADVERSE EVENT 65 0.0004
821 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
822 VISION BLURRED 49 0.0004
823 EMOTIONAL DISORDER 11 0.0004
824 PRURITUS 137 0.0004
825 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72 0.0004
826 DEVICE OCCLUSION 5 0.0004
827 ABDOMINAL DISTENSION 37 0.0004
828 HEART RATE IRREGULAR 8 0.0004
829 DYSPNOEA 200 0.0004
830 FLATULENCE 20 0.0004
831 METRORRHAGIA 6 0.0004
832 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
833 UPPER LIMB FRACTURE 7 0.0004
834 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
835 CHILLS 41 0.0003
836 ABDOMINAL PAIN 81 0.0003
837 OFF LABEL USE 304 0.0003
838 PAIN 213 0.0003
839 PAIN IN EXTREMITY 102 0.0003
840 DEAFNESS 9 0.0003
841 METABOLIC ACIDOSIS 11 0.0003
842 FLUID OVERLOAD 5 0.0003
843 EOSINOPHILIA 6 0.0003
844 LUNG NEOPLASM MALIGNANT 14 0.0003
845 THROMBOCYTOPENIA 38 0.0003
846 LYMPHADENOPATHY 12 0.0003
847 HOSPITALISATION 52 0.0003
848 BLISTER 19 0.0003
849 CARDIOMYOPATHY 5 0.0003
850 PULMONARY OEDEMA 15 0.0003
851 GASTROINTESTINAL DISORDER 30 0.0003
852 KNEE ARTHROPLASTY 7 0.0003
853 LACRIMATION INCREASED 10 0.0003
854 EXPIRED PRODUCT ADMINISTERED 11 0.0003
855 PELVIC PAIN 6 0.0003
856 RENAL FAILURE ACUTE 14 0.0003
857 BONE DISORDER 6 0.0003
858 GAIT INABILITY 11 0.0003
859 BURNING SENSATION 23 0.0003
860 INSURANCE ISSUE 5 0.0003
861 TENDONITIS 5 0.0003
862 AGRANULOCYTOSIS 6 0.0003
863 PRODUCT DISPENSING ERROR 7 0.0003
864 LEUKOPENIA 16 0.0003
865 MYALGIA 54 0.0003
866 CARDIOVASCULAR DISORDER 8 0.0003
867 CHEST DISCOMFORT 32 0.0003
868 RASH PAPULAR 7 0.0003
869 THROMBOSIS 25 0.0003
870 ANAPHYLACTIC SHOCK 8 0.0003
871 CHROMATURIA 7 0.0003
872 INFLAMMATION 16 0.0003
873 BLOOD GLUCOSE INCREASED 58 0.0003
874 PLASMA CELL MYELOMA 12 0.0003
875 MUCOSAL INFLAMMATION 8 0.0003
876 MUSCULOSKELETAL PAIN 16 0.0003
877 ARTHRITIS 24 0.0003
878 URTICARIA 51 0.0003
879 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
880 HAEMORRHAGE 31 0.0003
881 TASTE DISORDER 6 0.0003
882 OCULAR HYPERAEMIA 14 0.0003
883 PALLOR 8 0.0003
884 MULTIPLE SCLEROSIS 14 0.0003
885 SWELLING FACE 19 0.0003
886 BLOOD PRESSURE FLUCTUATION 7 0.0003
887 DEATH 250 0.0003
888 MULTI-ORGAN FAILURE 5 0.0003
889 DISEASE PROGRESSION 34 0.0003
890 BONE DENSITY DECREASED 9 0.0003
891 WHEEZING 17 0.0003
892 WOUND 8 0.0003
893 INTENTIONAL PRODUCT MISUSE 25 0.0003
894 VISUAL IMPAIRMENT 35 0.0003
895 AGEUSIA 7 0.0003
896 RECTAL HAEMORRHAGE 12 0.0003
897 GOUT 5 0.0003
898 MOBILITY DECREASED 20 0.0003
899 GASTRIC CANCER 7 0.0003
900 IMPAIRED HEALING 9 0.0003
901 DRUG RESISTANCE 7 0.0003
902 VISUAL ACUITY REDUCED 9 0.0003
903 PARAESTHESIA 42 0.0003
904 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
905 GASTRIC ULCER 5 0.0003
906 PULMONARY FIBROSIS 5 0.0003
907 DRY EYE 13 0.0003
908 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
909 MYOCARDIAL INFARCTION 45 0.0003
910 EMOTIONAL DISTRESS 31 0.0003
911 HYPOACUSIS 11 0.0003
912 INFLUENZA LIKE ILLNESS 21 0.0003
913 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
914 RASH ERYTHEMATOUS 12 0.0003
915 PRODUCT USE IN UNAPPROVED INDICATION 62 0.0002
916 HIP FRACTURE 8 0.0002
917 FLUSHING 25 0.0002
918 EYE SWELLING 9 0.0002
919 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
920 NEEDLE ISSUE 7 0.0002
921 SKIN DISCOLOURATION 11 0.0002
922 DRUG WITHDRAWAL SYNDROME 21 0.0002
923 ERYTHEMA 49 0.0002
924 DRUG INTOLERANCE 23 0.0002
925 CATARACT 14 0.0002
926 INFECTION 34 0.0002
927 APHASIA 7 0.0002
928 CEREBROVASCULAR ACCIDENT 39 0.0002
929 NEOPLASM PROGRESSION 8 0.0002
930 PRODUCT PRESCRIBING ISSUE 5 0.0002
931 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
932 JOINT STIFFNESS 6 0.0002
933 PERIPHERAL SWELLING 35 0.0002
934 EYE IRRITATION 13 0.0002
935 MENSTRUATION IRREGULAR 6 0.0002
936 GLOSSODYNIA 5 0.0002
937 MYELOSUPPRESSION 8 0.0002
938 BONE PAIN 13 0.0002
939 RESPIRATORY DISTRESS 6 0.0002
940 ANAPHYLACTIC REACTION 12 0.0002
941 MUSCULOSKELETAL STIFFNESS 19 0.0002
942 ILL-DEFINED DISORDER 13 0.0002
943 ARTHRALGIA 86 0.0002
944 ALOPECIA 40 0.0002
945 SKIN EXFOLIATION 17 0.0002
946 EXTRA DOSE ADMINISTERED 8 0.0002
947 SKIN IRRITATION 9 0.0002
948 NEOPLASM MALIGNANT 13 0.0002
949 NERVOUS SYSTEM DISORDER 6 0.0002
950 ECZEMA 10 0.0002
951 SKIN LESION 5 0.0002
952 SWELLING 17 0.0002
953 LIP SWELLING 6 0.0002
954 NEUTROPENIA 24 0.0002
955 RHEUMATOID ARTHRITIS 20 0.0002
956 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
957 INFUSION RELATED REACTION 11 0.0002
958 JOINT SWELLING 20 0.0002
959 CORONARY ARTERY DISEASE 5 0.0002
960 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
961 INJECTION SITE RASH 5 0.0002
962 PRODUCT QUALITY ISSUE 22 0.0002
963 GYNAECOMASTIA 5 0.0002
964 EXPOSURE DURING PREGNANCY 10 0.0002
965 ACNE 12 0.0002
966 SKIN DISORDER 5 0.0001
967 ABORTION SPONTANEOUS 6 0.0001
968 EYE PRURITUS 5 0.0001
969 BLINDNESS 6 0.0001
970 TREATMENT FAILURE 12 0.0001
971 ARTHROPATHY 8 0.0001
972 DRUG DEPENDENCE 23 0.0001
973 DEVICE DISLOCATION 6 0.0001
974 DRY SKIN 18 0.0001
975 THERAPY NON-RESPONDER 6 0.0001
976 DISEASE RECURRENCE 6 0.0001
977 COLORECTAL CANCER 6 0.0001
978 INJECTION SITE BRUISING 10 0.0001
979 PRODUCT SUBSTITUTION ISSUE 7 0.0001
980 VAGINAL HAEMORRHAGE 5 0.0001
981 DERMATITIS ATOPIC 6 0.0001
982 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
983 INJECTION SITE ERYTHEMA 13 0.0001
984 PRODUCT STORAGE ERROR 9 0.0001
985 DEVICE ISSUE 9 0.0001
986 SKIN BURNING SENSATION 7 0.0001
987 BREAST CANCER 9 0.0001
988 PSORIASIS 10 0.0001
989 INJECTION SITE REACTION 5 0.0001
990 DRUG ABUSE 6 0.0001
991 INJECTION SITE PAIN 18 0.0001
992 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001